1. Chemoimmunotherapy resistant follicular lymphoma: predictors of resistance, association with transformation and prognosis. Issue 11 (November 2014) Authors: Mozessohn, Lee; Cheung, Matthew C.; Crump, Michael; Buckstein, Rena; Berinstein, Neil; Imrie, Kevin; Kuruvilla, John; Piliotis, Eugenia; Kukreti, Vishal Journal: Leukemia & lymphoma Issue: Volume 55:Issue 11(2014:Nov.) Page Start: 2502 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 356 Baseline PD-L1 expression and tumor immune infiltration is associated with clinical response in patients with r/r DLBCL treated with DPX-Survivac, low-dose cyclophosphamide and pembrolizumab. (9th November 2020) Authors: Berinstein, Neil; Bence-Bruckler, Isabelle; Forward, Nick; Laneuville, Pierre; Mangel, Joy; Stewart, Douglas; Amitai, Irina; Klein, Gail; Pennell, Nancy; Rashedi, Iran; Roos, Kim; Bramhecha, Yogesh; Conlon, Rebekah Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A217 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 356 Baseline PD-L1 expression and tumor immune infiltration is associated with clinical response in patients with r/r DLBCL treated with DPX-Survivac, low-dose cyclophosphamide and pembrolizumab. (9th November 2020) Authors: Berinstein, Neil; Bence-Bruckler, Isabelle; Forward, Nick; Laneuville, Pierre; Mangel, Joy; Stewart, Douglas; Amitai, Irina; Klein, Gail; Pennell, Nancy; Rashedi, Iran; Roos, Kim; Bramhecha, Yogesh; Conlon, Rebekah Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A381 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Multi-modal treatment with peptide vaccine, metronomic cyclophosphamide and anti-PD1 monoclonal antibody provides effective control of tumors in multiple models. (6th November 2014) Authors: Weir, Genevieve; Hrytsenko, Olga; Stanford, Marianne; Berinstein, Neil; Liwski, Robert; Karkada, Mohan; Mansour, Marc Journal: Journal for immunotherapy of cancer Issue: Volume 2(2014)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Plasma biomarker analysis of ovarian cancer patients undergoing immunotherapy with therapeutic cancer vaccine DPX-Survivac. (4th November 2015) Authors: Karkada, Mohan; Pinto, Devanand; Teh, Eve; Chisholm, Kenneth; Quinton, Tara; Berinstein, Neil; Mansour, Marc Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Immunological and polyfunctional T cell profiling following therapy with DPX-Survivac as a predictive tool of vaccine efficacy. (7th November 2013) Authors: Karkada, Mohan; Ogura, Mieko; Tovar, Vivian; Mitsuhashi, Masato; Berinstein, Neil; Mansour, Marc Journal: Journal for immunotherapy of cancer Issue: Volume 1(2013)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Plasma biomarker analysis of ovarian cancer patients undergoing immunotherapy with therapeutic cancer vaccine DPX-Survivac. Issue 2 (December 2015) Authors: Karkada, Mohan; Pinto, Devanand; Teh, Eve; Chisholm, Kenneth; Quinton, Tara; Berinstein, Neil; Mansour, Marc Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Anti-PD-1 increases the clonality and activity of tumor infiltrating antigen specific T cells induced by a potent immune therapy consisting of vaccine and metronomic cyclophosphamide. Issue 1 (December 2016) Authors: Weir, Genevieve; Hrytsenko, Olga; Quinton, Tara; Berinstein, Neil; Stanford, Marianne; Mansour, Marc Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Autologous stem cell transplant and combination immunotherapy of rituximab and interferon‐α induces prolonged clinical and molecular remissions in patients with follicular lymphoma. (30th January 2018) Authors: Smyth, Liam; Buckstein, Rena; Pennell, Nancy; Weerasinghe, Rashmi; Cheung, Matthew C.; Imrie, Kevin; Spaner, David; Piliotis, Eugenia; Chodirker, Lisa; Reis, Marciano; Ghorab, Zeina; Zhang, Liying; Boudreau, Violet; Miliken, Angela; Berinstein, Neil Journal: British journal of haematology Issue: Volume 184:Number 3(2019) Page Start: 469 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Chemoimmunotherapy resistant follicular lymphoma: predictors of resistance, association with transformation and prognosis. Issue 11 (November 2014) Authors: Mozessohn, Lee; Cheung, Matthew C.; Crump, Michael; Buckstein, Rena; Berinstein, Neil; Imrie, Kevin; Kuruvilla, John; Piliotis, Eugenia; Kukreti, Vishal Journal: Leukemia & lymphoma Issue: Volume 55:Issue 11(2014:Nov.) Page Start: 2502 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗